Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-000893
Filing Date
2022-01-11
Accepted
2022-01-11 08:15:27
Documents
2
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 17346
2 ex99-1.htm EX-99.1 12097
  Complete submission text file 0001493152-22-000893.txt   30442
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 22522791
SIC: 2834 Pharmaceutical Preparations